TipRanks
Australian Clinical Labs Ltd (AU:ACL)
ASX:ACL
Australian Market
ACL
Australian Clinical Labs Ltd
RESEARCH TOOLSreports
Want to see AU:ACL full AI Analyst Report?

Australian Clinical Labs Ltd (ACL) Ratios

80 Followers

Australian Clinical Labs Ltd Ratios

AU:ACL's free cash flow for Q4 2026 was AU$0.22. For the 2026 fiscal year, AU:ACL's free cash flow was decreased by AU$ and operating cash flow was AU$0.11. See a summary of the company’s cash flow.
Ratios
TTM
Jun 26Jun 25Jun 24Jun 23
Liquidity Ratios
Current Ratio
 0.54 0.54 0.55 0.64 0.62
Quick Ratio
 0.47 0.47 0.48 0.56 0.54
Cash Ratio
 0.12 0.12 0.10 0.13 0.11
Solvency Ratio
 0.36 0.36 0.11 0.37 0.39
Operating Cash Flow Ratio
 0.78 0.78 0.84 0.77 0.76
Short-Term Operating Cash Flow Coverage
 1.51 1.51 0.00 0.00 0.00
Net Current Asset Value
AU$ -329.97MAU$ -329.97MAU$ -282.79MAU$ -281.69MAU$ -290.28M
Leverage Ratios
Debt-to-Assets Ratio
 0.57 0.57 0.51 0.52 0.55
Debt-to-Equity Ratio
 2.26 2.26 1.69 1.74 1.83
Debt-to-Capital Ratio
 0.69 0.69 0.63 0.64 0.65
Long-Term Debt-to-Capital Ratio
 0.29 0.29 0.20 0.24 0.28
Financial Leverage Ratio
 3.96 3.96 3.35 3.34 3.36
Debt Service Coverage Ratio
 1.42 1.45 3.59 9.24 12.45
Interest Coverage Ratio
 3.18 3.33 14.75 3.34 4.04
Debt to Market Cap
 0.32 0.40 0.08 0.11 0.10
Interest Debt Per Share
 1.86 1.86 1.62 1.64 1.65
Net Debt to EBITDA
 1.61 1.59 3.31 1.67 1.60
Profitability Margins
Gross Profit Margin
20.59%20.59%36.54%20.07%81.78%
EBIT Margin
8.04%8.43%9.17%5.98%8.98%
EBITDA Margin
26.59%26.98%10.98%24.60%26.72%
Operating Profit Margin
8.04%8.43%36.54%8.25%8.10%
Pretax Profit Margin
5.13%5.13%6.50%5.27%6.98%
Net Profit Margin
3.25%3.25%4.37%3.47%5.19%
Continuous Operations Profit Margin
3.29%3.29%4.43%3.52%5.21%
Net Income Per EBT
63.41%63.41%67.31%65.81%74.31%
EBT Per EBIT
63.77%60.81%17.79%63.91%86.17%
Return on Assets (ROA)
4.00%4.00%5.64%4.04%6.20%
Return on Equity (ROE)
15.80%15.86%18.93%13.48%20.82%
Return on Capital Employed (ROCE)
15.32%16.06%75.57%14.77%14.34%
Return on Invested Capital (ROIC)
7.67%8.04%39.51%7.74%8.50%
Return on Tangible Assets
5.54%5.54%7.92%5.59%8.68%
Earnings Yield
4.34%5.52%6.13%4.79%5.20%
Efficiency Ratios
Receivables Turnover
 10.82 10.82 10.54 8.47 9.23
Payables Turnover
 10.99 34.65 22.90 21.05 7.02
Inventory Turnover
 40.66 40.66 30.11 32.76 8.35
Fixed Asset Turnover
 2.48 2.48 2.74 2.45 2.40
Asset Turnover
 1.23 1.23 1.29 1.16 1.20
Working Capital Turnover Ratio
 -8.18 -7.55 -8.70 -9.44 -8.97
Cash Conversion Cycle
 9.50 32.19 30.82 36.90 31.21
Days of Sales Outstanding
 33.75 33.75 34.63 43.09 39.53
Days of Inventory Outstanding
 8.98 8.98 12.12 11.14 43.69
Days of Payables Outstanding
 33.23 10.53 15.94 17.34 52.01
Operating Cycle
 42.72 42.72 46.75 54.23 83.22
Cash Flow Ratios
Operating Cash Flow Per Share
 0.85 0.85 0.96 0.80 0.72
Free Cash Flow Per Share
 0.80 0.80 0.92 0.77 0.68
CapEx Per Share
 0.05 0.05 0.04 0.03 0.03
Free Cash Flow to Operating Cash Flow
 0.94 0.94 0.95 0.96 0.95
Dividend Paid and CapEx Coverage Ratio
 4.78 4.78 5.48 6.03 1.38
Capital Expenditure Coverage Ratio
 17.05 17.05 21.73 24.53 20.72
Operating Cash Flow Coverage Ratio
 0.48 0.48 0.63 0.52 0.45
Operating Cash Flow to Sales Ratio
 0.22 0.22 0.25 0.23 0.21
Free Cash Flow Yield
28.87%35.78%32.98%30.66%19.82%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 22.98 18.67 16.35 20.86 19.22
Price-to-Sales (P/S) Ratio
 0.73 0.59 0.71 0.72 1.00
Price-to-Book (P/B) Ratio
 3.63 2.87 3.09 2.81 4.00
Price-to-Free Cash Flow (P/FCF) Ratio
 3.45 2.79 3.03 3.26 5.05
Price-to-Operating Cash Flow Ratio
 3.33 2.63 2.89 3.13 4.80
Price-to-Earnings Growth (PEG) Ratio
 -0.69 -0.63 0.39 -0.63 -0.24
Price-to-Fair Value
 3.63 2.87 3.09 2.81 4.00
Enterprise Value Multiple
 4.34 3.77 9.80 4.61 5.33
Enterprise Value
 845.18M 742.28M 797.71M 782.01M 986.32M
EV to EBITDA
 4.36 3.77 9.80 4.61 5.33
EV to Sales
 1.16 1.02 1.08 1.13 1.43
EV to Free Cash Flow
 5.50 4.83 4.57 5.11 7.21
EV to Operating Cash Flow
 5.18 4.55 4.36 4.90 6.86
Tangible Book Value Per Share
 -0.08 -0.08 0.04 0.06 0.04
Shareholders’ Equity Per Share
 0.78 0.78 0.90 0.89 0.86
Tax and Other Ratios
Effective Tax Rate
 0.36 0.36 0.32 0.33 0.25
Revenue Per Share
 3.82 3.80 3.90 3.47 3.45
Net Income Per Share
 0.12 0.12 0.17 0.12 0.18
Tax Burden
 0.63 0.63 0.67 0.66 0.74
Interest Burden
 0.64 0.61 0.71 0.88 0.78
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.13 0.12 0.44 0.45 0.43
Stock-Based Compensation to Revenue
 0.00 0.00 <0.01 <0.01 <0.01
Income Quality
 6.89 6.89 5.64 6.67 4.00
Currency in AUD